Pfizer: Obesity Hype And Vaccine Policy Shocks
Source: SeekingAlpha
2026-03-05 06:00:58 ET
Performance assessment
Pfizer ( PFE ) has outperformed the S&P500 broader market index since my last update on the stock:
Performance since Author's Last Article on PFE (Seeking Alpha, Author's Last Article on PFE)
Read the full article on Seeking Alpha
For further details see:
Pfizer: Obesity Hype And Vaccine Policy Shocks
Novo Nordisk A/S
NASDAQ: NVO
NVO Trading
0.69% G/L:
$38.88 Last:
4,716,867 Volume:
$38.73 Open:
NVO Latest News
March 09, 2026 12:44:07 pm
Hims & Hers Health Shares Skyrocket on Novo Nordisk Deal, but Is the Stock Still a Buy?
March 09, 2026 12:20:00 pm
Novo Nordisk Is Slashing Prices for Ozempic and Wegovy. Here's Why That Might End Up Helping the Stock
NVO Stock Data
$220,548,675,000
4,194,421,000
N/A
749
N/A
Biotechnology & Life Sciences
Healthcare
DK
Bagsvaerd
